SEARCH

SEARCH BY CITATION

References

  • 1
    Jakkimainen RL, Boyle E, Tudiver F. Is Helicobacter associated with non ulcer dyspepsia and will eradication improve symptoms? A meta-analysis. Br Med J 1999; 0: 10404.
  • 2
    Talley NJ. A critique of therapeutic trials in Helicobacter pylori positive dyspepsia. Gastroenterology 1994; 106: 117483.
  • 3
    Gilvarry J, Buckley MJ, Beattie S, Hamilton H, O'Morain C. Eradication of H. pylori affects symptoms in non-ulcer dyspepsia. Scand J Gastroenterol 1997; 32(0): 53540.
  • 4
    Laheij RJF, Jansen JBMJ, Vandelisdonk EH, Verbeek ALM. Symptom improvement through eradication of H. pylori with non-ulcer dyspepsia. Aliment Pharmacol Ther 1996; 10: 84350.
  • 5
    Soo S, Moayyedi P, Deeks J, et al. Helicobacter pylori eradication for non-ulcer dyspepsia (full Cochrane Review). Oxford Update Software 2000.
  • 6
    Malfertheiner P (for European Helicobacter Study Group). Current European concepts in the management of Helicobacter pylori infection — the Maastricht Consensus Report. Gut 1997; 41(1): 813.
  • 7
    Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of H. pylori infection — the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 16780.
  • 8
    Blum AL, Talley NJ, O'Morain C, et al. Lack of effect of treating H. pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998; 339: 187581.
  • 9
    Talley NJ, Janssens J, Lauritsen K, Tacz I, Bolling-Sternevald E. Eradication of H. pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. Br Med J 1999; 318: 8337.
  • 10
    Talley NJ, Vakil N, Ballard D, Fennerty MB. Absence of benefit of eradicating H. pylori in patients with non-ulcer dyspepsia. N Engl J Med 1999; 341: 110611.
  • 11
    McColl KEL, Murray L, El-Omar E, et al. Symptomatic benefit from eradicating H. pylori infection in patients with non-ulcer dyspepsia. N Engl J Med 1998; 339(26): 186974.
  • 12
    Danesh J, Pounder RE. Eradication of Helicobacter pylori and non-ulcer dyspepsia. Lancet 2000; 4(355): 7667.
  • 13
    Moayyedi P, Soo S, Deeks J, et al. on behalf of the Dyspepsia Review Group. Symptomatic review and economic evaluation of H. pylori eradication treatment for non-ulcer dyspepsia. Br Med J 2000; 321: 65964.
  • 14
    Laine L, Schoenfeldt P, Fennerty MB. Therapy for H. pylori in patients with non-ulcer dyspepsia. Ann Intern Med 2001; 134: 3619.
  • 15
    Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. Am J Surg Pathol 1996; 20: 116181.
  • 16
    Leodolter A, Dominguez-Munoz E, Von Arnim U, Kahl S, Peitz U, Malfertheiner P. Validity of a modified 13C-urea breath test for pre- and posttreatment diagnosis of Helicobacter pylori infection in the routine clinical setting. Am J Gastroenterol 1999; 94(8): 21004.
    Direct Link:
  • 17
    Clopper CP, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binominal. Biometrika 1934; 26: 40413.
  • 18
    McColl K, Malfertheiner P. Helicobacter pylori and functional dyspepsia. Curr Opin Gastroenterol 2000; 16(Suppl.): S2932.
  • 19
    Greenberg PD, Cello JP. Lack of effect of treatment for H. pylori on symptoms of nonulcer dyspepsia. Arch Intern Med 1999; 159: 22838.
  • 20
    McColl K, El-Nujumi A, Murray L, et al. The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients. Gut 1997; 40(3): 3026.
  • 21
    Trespi E, Broglia F, Villani L, Luinetti O, Fiocca R, Solcia E. Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after H. pylori eradication. Scand J Gastroenterol 1994; 29(10): 8848.
  • 22
    Forbes GM, Foster NM. Patient recruitment in H. pylori drug trials. Lancet 1998; 352: 10712.
  • 23
    Talley NJ, Janssens J, Lauritsen K, Racz I, Bolling-Sternevald E. Eradication of H. pylori in functional dyspepsia; randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group. Br Med J 1999; 318: 8337.
  • 24
    Finnicy JS, Kinnersley N, Hughes M, et al. Metaanalysis of antisecretory and gastrokinetic compounds in functional dyspepsia. J Clin Gastroenterol 1998; 26: 31220.
  • 25
    Labenz J, Blutm AL, Bayerdörffer E, et al. Curing Helicobacter pylori infection in patients with duodenal ulcer disease may provoke reflux esophagitis. Gastroenterology 1997; 112: 14427.
  • 26
    Fallone CA, Barkun AN, Friedman G, et al. Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? Am J Gastroenterol 2000; 95: 91420.
    Direct Link:
  • 27
    Hamada H, Haruma K, Mihara M, et al. High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis. Aliment Pharmacol Ther 2000; 14: 72935.
  • 28
    Malfertheiner P, Dent J, Zeijlon L, et al. Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease – results from a randomized trial programme. Aliment Pharmacol Ther 2002; 16: 143142.
  • 29
    Vakil N, Hahn B, McSorley D. Recurrent symptoms and gastro-oesophageal reflux disease in patients with duodenal ulcer treated for H. pylori infection. Aliment Pharmacol Ther 2000; 14(1): 4551.